CRISPR Cas 专利档案，第 1 部分：Cas9-10 年中场时我们站在哪里？
The CRISPR Cas patent files, part 1: Cas9 - Where to we stand at the 10 year halftime?
机构信息
Michalski Hüttermann & Partner Patentanwälte mbB, Düsseldorf, Germany.
出版信息
J Biotechnol. 2024 Jan 10;379:46-52. doi: 10.1016/j.jbiotec.2023.11.003. Epub 2023 Nov 19.
Abstract
CRISPR Cas9 has turned out to be one of the most influential technologies in the life sciences. However, ferocious patent debates and an unclear licensing situation makes access to this technology difficult for Small and medium enterprises. This article gives an overview of the status quo 10 years after the seminal patents were filed.
摘要
CRISPR Cas9 已成为生命科学领域最具影响力的技术之一。然而，激烈的专利之争和不明确的授权情况使得中小企业难以获得这项技术。本文概述了基础专利申请 10 年后的现状。
Zotero 插件